GSK ends Arzerra patent dispute with Genentech and nonprofit

03/27/2012 | Reuters

Genmab said marketing partner GlaxoSmithKline resolved a patent dispute with Roche Holding unit Genentech and California nonprofit City of Hope concerning Genmab's blood cancer drug Arzerra, or ofatumumab.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA